References
- Cartwright R, Brincker H, Carli PM, . The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer 1999;35:627–633.
- Morgan G, Vornanen M, Puitinen J, . Changing trends in the incidence of non-Hodgkin's lymphoma in Europe. Biomed Study Group. Ann Oncol 1997;8(Suppl. 2):49–54.
- Noronha V, Shafi NQ, Obando JA, Kummar S. Primary non-Hodgkin's lymphoma of the liver. Crit Rev Oncol Hematol 2005;53: 199–207.
- Swerdlow SH, Campo E, Harris NL, . WHO classification of tumours of haematopoietic and lymphoid tissues. 4th. Lyon: IARC; 2008.
- Loddenkemper C, Longerich T, Hummel M, . Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification. Virchows Arch 2007;450:493–502.
- Weiler-Sagie M, Bushelev O, Epelbaum R, . (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 2010;51:25–30.
- Khong PL, Pang CB, Liang R, Kwong YL, Au WY. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol 2008;87:613–621.
- Lei KI. Primary non-Hodgkin's lymphoma of the liver. Leuk Lymphoma 1998;29:293–299.
- Bronowicki JP, Bineau C, Feugier P, . Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology 2003;37:781–787.
- Avlonitis VS, Linos D. Primary hepatic lymphoma: a review. Eur J Surg 1999;165:725–729.
- Page RD, Romaguera JE, Osborne B, . Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer 2001;92:2023–2029.
- Teusink AC, Hall PD. Toxicities of gemcitabine in patients with severe hepatic dysfunction. Ann Pharmacother 2010;44: 750–754.
- Micromedex® Healthcare Series [Internet]. Greenwood Village, CO: Thomson Healthcare [cited 25 October 2006]. Available from: http://www.micromedex.com
- McEvoy GK, Snow E, Kester L. AHFS 2006 drug information. Bethesda, MD: American Society of Health-System Pharmacists; 2010. 1197–1198.
- Kitzen JJ, Puozzo C, de Jonge MJ, Brandely M, Verweij J. Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: results of a pharmacokinetic study. Eur J Cancer 2010;46:266–269.
- Gallamini A, Hutchings M, Rigacci L, . Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 2007;25:3746–3752.
- Larouche JF, Berger F, Chassagne-Clement C, . Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome. J Clin Oncol 2010;28:2094–2100.